NASDAQ:CRDF

Cardiff Oncology Stock Predictions

Healthcare > Biotechnology

Buy CRDF

*Your capital is at risk

$1.40

-0.110 (-7.28%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CRDF Prediction Chart

CRDF Predictions History

Latest community submissions for CRDF.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jun 27, 2022	$2.14 -5.73%	$2.22	V	96.40%	1
connorjmeier	Jun 27, 2022	$2.21 -2.64%	$2.22	V	99.55%	5
Sagar Patil @SagarPatil.189820	Jun 27, 2022	$2.20 -3.93%	$2.22	V	99.10%	2
JS Pro	Jun 13, 2022	$2.01 -6.07%	$1.92	V	95.31%	1
titrolospe	Jun 13, 2022	$2.80 +24.44%	$1.92	X	54.17%	0
JS Pro	Apr 19, 2022	$1.57 -6.55%	$1.64	V	95.73%	1
JS Pro	Feb 25, 2021	$10.70 +9.74%	$9.75	X	90.26%	0
Kevin Ripper @KevinRipper.214730	Feb 25, 2021	$11.28 +15.69%	$9.75	X	84.31%	0
sander7100 yo bro Pro @sander7100yobro.167552	Sep 28, 2020	$11.66 -4.27%	$12.18	X	95.73%	1
JS Pro	Sep 28, 2020	$11.68 -4.11%	$12.18	X	95.89%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRDF with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CARDIFF ONCOLOGY INC.

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by